Skip to main content

Closed

NDRA: ENDRA Life Sciences Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-236.3%

Financially safe

Stretched

Debt / equity0.26×

Interest coverage0.0×

Current ratio0.64×

ENDRA Life Sciences Inc.

NDRANASDAQ Capital Market·USD·Closed

ENDRA Life Sciences Inc.

NDRANASDAQ·USD·Closed

$4.70

+8.55%

$4.70

+$0.37 (8.55%)

52W Range

25thpctl

Volume

0.57×avg

Mkt Cap

3.54MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

25thpctl

Volume

0.57×avg

Market Cap

3.54MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings